Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus-Reference-Cited by-同舟云学术

Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

Published:2023-11-04 Issue:21 Volume:12 Page:6929
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Awadhi Sameer Al¹^ORCID,Alboraie Mohamed²^ORCID,Albaba Emad Aldin³,Almutairdi Abdulelah⁴,Alsaad Monther⁵,Azzam Nahla⁶,Barakat Husam⁷,D’Amico Ferdinando⁸⁹,Danese Silvio⁸,El Kady Mohamed¹⁰,Ghoneim Hossam¹¹,Hamoudi Waseem¹²^ORCID,Jazzar Ahmad¹³,Mosli Mahmoud¹⁴^ORCID,Shehab Hany¹⁵,Sneineh Awni Abu¹⁶

Affiliation:

1. Digestive Diseases Unit, Rashid Hospital, Dubai 003206, United Arab Emirates

2. Department of Internal Medicine, Al-Azhar University, Cairo 11884, Egypt

3. Department of Medicine, Almana General Hospital, Alkhobar 31952, Saudi Arabia

4. Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia

5. Al Madar Medical Centre, Sharjah P.O. Box 80789, United Arab Emirates

6. Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia

7. Department of Gastroenterology, Yarmouk University, Irbid 21163, Jordan

8. Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, 20132 Milan, Italy

9. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20132 Milan, Italy

10. Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo 11559, Egypt

11. Immunology and Allergy Department, Medical Research Institute, Alexandria University, Alexandria 5424041, Egypt

12. Internal Medicine Department, Al-Bashir Hospital, Amman 11151, Jordan

13. Gastroenterology Division, Sheikh Khalifa Medical City, Abu Dhabi 51900, United Arab Emirates

14. Department of Medicine, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia

15. Integrated Clinical and Research Center for Intestinal Disorders (ICRID), Gastroenterology Division, Endemic Medicine Department, Cairo University, Cairo 3725121, Egypt

16. Gastroenterology and Hepatology, University of Jordan, Amman 11942, Jordan

Abstract

The prevalence of ulcerative colitis (UC) in the Middle East is increasing, impacting the economic and healthcare burden. The management of patients with mild to moderate UC is still a challenge as several factors can affect optimal care, including drug choice, induction and maintenance dose, treatment optimization and de-escalation, therapy duration, monitoring, and safety profile. We conducted an expert consensus to standardize the management of patients with mild to moderate UC. Sixteen experts in inflammatory bowel diseases, through a well-established and accepted Delphi methodology, voted and approved eight statements in order to provide practical guidance to clinicians in the Middle East.

Funder

Ferring

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/12/21/6929/pdf

Reference65 articles.

1. Ulcerative colitis;Ungaro;Lancet Lond. Engl.,2017

2. GBD 2017 Inflammatory Bowel Disease Collaborators (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol., 5, 17–30.

3. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations’ Consortium;Banerjee;J. Gastroenterol. Hepatol.,2022

4. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment;Raine;J. Crohns Colitis,2022

5. Johansen, I., Småstuen, M.C., Løkkeberg, S.T., Kristensen, V.A., Høivik, M.L., Lund, C., Olsen, B., Strande, V., Huppertz-Hauss, G., and Aabrekk, T.B. (2023). Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: Results from the IBSEN III Study. BMC Gastroenterol., 23.